Given that milk EVs remain stable in circulation and exert anti-inflammatory effects through TLR4 inhibition, it is plausible that they may also confer protective effects against endothelial dysfunction, a key contributor to cardiovascular diseases. This evidence concerns the gene TLR4 and cardiovascular disorder.